• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致力于体外肝脏清除研究中检测方法的协调统一。

Towards harmonization of test methods for in vitro hepatic clearance studies.

机构信息

Wageningen Food Safety Research (WFSR), part of Wageningen University and Research, Wageningen, the Netherlands.

Wageningen Food Safety Research (WFSR), part of Wageningen University and Research, Wageningen, the Netherlands.

出版信息

Toxicol In Vitro. 2020 Mar;63:104722. doi: 10.1016/j.tiv.2019.104722. Epub 2019 Nov 20.

DOI:10.1016/j.tiv.2019.104722
PMID:31756541
Abstract

Non-animal methods for toxicokinetics, such as in vitro hepatic metabolic clearance studies, play an important role in chemical risk evaluations. To gain regulatory acceptance of such clearance data, the development of a test guideline for performing in vitro hepatic clearance studies is crucial. The aim of the present study was to obtain insight in the experimental conditions of clearance studies that influence obtained intrinsic clearance (CLint) values. To that end, in vitro hepatic CLint data obtained with rat or human hepatocytes and methodological aspects of the experiments, were collected from 42 different suitable studies published between 1995 and 2018. The CLint values for the majority of chemicals differed by more than one order of magnitude. We estimated the systematic effect of different experimental setups on the CLint values using a random forest regression analysis, revealing that 'hepatocyte concentration', 'species' (rat or human hepatocytes) and 'culture medium' have the largest impact. Calculating unbound CLint (CLint,u) values slightly reduced the variation for most chemicals. Given that in vivo clearance is in general underpredicted based on in vitro clearance data, a harmonized protocol is preferably based on a protocol that provides relatively high in vitro CLint values.

摘要

非动物毒代动力学方法,如体外肝代谢清除研究,在化学风险评估中起着重要作用。为了使此类清除数据得到监管部门的认可,制定进行体外肝清除研究的试验指南至关重要。本研究的目的是了解影响获得的内在清除率(CLint)值的清除研究的实验条件。为此,从 1995 年至 2018 年发表的 42 项合适的研究中收集了用大鼠或人肝细胞进行的体外肝 CLint 数据以及实验的方法学方面。大多数化学物质的 CLint 值相差一个以上数量级。我们使用随机森林回归分析估计了不同实验设置对 CLint 值的系统影响,结果表明“肝细胞浓度”、“物种”(大鼠或人肝细胞)和“培养基”的影响最大。计算未结合的 CLint(CLint,u)值可使大多数化学物质的变异性略有降低。鉴于基于体外清除数据,体内清除通常被低估,因此,优选基于提供相对较高体外 CLint 值的方案的协调方案。

相似文献

1
Towards harmonization of test methods for in vitro hepatic clearance studies.致力于体外肝脏清除研究中检测方法的协调统一。
Toxicol In Vitro. 2020 Mar;63:104722. doi: 10.1016/j.tiv.2019.104722. Epub 2019 Nov 20.
2
Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation.血浆蛋白结合在药物清除率预测中的影响:已发表研究的数据库分析及对体外-体内外推的启示
Drug Metab Dispos. 2021 Mar;49(3):188-201. doi: 10.1124/dmd.120.000294. Epub 2020 Dec 18.
3
Use of Segregated Hepatocyte Scaling Factors and Cross-Species Relationships to Resolve Clearance Dependence in the Prediction of Human Hepatic Clearance.使用隔离的肝细胞缩放因子和跨物种关系来解决预测人体肝脏清除率中的清除率依赖性。
Drug Metab Dispos. 2019 Mar;47(3):320-327. doi: 10.1124/dmd.118.085191. Epub 2019 Jan 4.
4
Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.基于在体猴药代动力学研究和肝细胞体外代谢稳定性试验预测人肝 P450 和非 P450 底物的清除率的定量研究。
AAPS J. 2019 Jan 23;21(2):20. doi: 10.1208/s12248-019-0294-1.
5
Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches.不同体外-体内外推方法预测有机阴离子转运多肽底物类药物人体肝清除率的比较。
J Pharm Sci. 2017 Sep;106(9):2678-2687. doi: 10.1016/j.xphs.2017.02.012. Epub 2017 Feb 24.
6
Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds.使用HμREL人共培养系统预测缓慢代谢化合物的内在清除率和代谢物形成
Mol Pharm. 2016 Aug 1;13(8):2796-807. doi: 10.1021/acs.molpharmaceut.6b00396. Epub 2016 Jul 14.
7
In vivo clearance of ethoxycoumarin and its prediction from In vitro systems. Use Of drug depletion and metabolite formation methods in hepatic microsomes and isolated hepatocytes.乙氧香豆素的体内清除率及其体外系统预测。肝微粒体和分离肝细胞中药物消耗和代谢物形成方法的应用。
Drug Metab Dispos. 1998 Mar;26(3):216-21.
8
Evaluation and comparison of in vitro intrinsic clearance rates measured using cryopreserved hepatocytes from humans, rats, and rainbow trout.采用人、大鼠和虹鳟鱼冻存肝细胞评估和比较体外内在清除率。
Toxicology. 2021 Jun 15;457:152819. doi: 10.1016/j.tox.2021.152819. Epub 2021 May 10.
9
In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes.在体-体外外推和清除人类和临床前物种的肝微粒体和肝细胞的比例因子。
AAPS J. 2023 Apr 13;25(3):40. doi: 10.1208/s12248-023-00800-x.
10
A Machine Learning Framework to Improve Rat Clearance Predictions and Inform Physiologically Based Pharmacokinetic Modeling.一种机器学习框架,用于提高大鼠清除预测并为基于生理的药代动力学建模提供信息。
Mol Pharm. 2023 Oct 2;20(10):5052-5065. doi: 10.1021/acs.molpharmaceut.3c00374. Epub 2023 Sep 15.

引用本文的文献

1
Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference.利用开源解决方案:首届开放系统药理学(OSP)社区会议的见解
CPT Pharmacometrics Syst Pharmacol. 2025 May;14(5):822-827. doi: 10.1002/psp4.70028. Epub 2025 Apr 3.
2
ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application.经皮应用 3 种高蛋白结合度紫外线滤光剂的 ADME 特征描述和 PBK 模型开发。
Toxicol Sci. 2023 Oct 30;196(1):1-15. doi: 10.1093/toxsci/kfad081.
3
Risk assessment in the 21st century: where are we heading?
21世纪的风险评估:我们正走向何方?
Toxicol Res (Camb). 2023 Jan 10;12(1):1-11. doi: 10.1093/toxres/tfac087. eCollection 2023 Feb.
4
Big Question to Developing Solutions: A Decade of Progress in the Development of Aquatic New Approach Methodologies from 2012 to 2022.重大问题解决方案:2012 年至 2022 年,水生新方法学发展十年进展。
Environ Toxicol Chem. 2024 Mar;43(3):559-574. doi: 10.1002/etc.5578. Epub 2023 Mar 20.
5
Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment.为了在化学风险评估中更好地利用和接受通用基于生理的动力学 (PBK) 模型进行体外-体内外推 (IVIVE),实现最佳效果。
Arch Toxicol. 2022 Dec;96(12):3407-3419. doi: 10.1007/s00204-022-03356-5. Epub 2022 Sep 5.
6
Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative metabolism studies.植物保护产品及其残留科学小组(PPR小组)关于比较代谢研究的测试与解读的科学意见。
EFSA J. 2021 Dec 23;19(12):e06970. doi: 10.2903/j.efsa.2021.6970. eCollection 2021 Dec.
7
Recent developments in and models for improved translation of preclinical pharmacokinetics and pharmacodynamics data.临床前药代动力学和药效学数据转化的 和 模型的最新进展。
Drug Metab Rev. 2021 May;53(2):207-233. doi: 10.1080/03602532.2021.1922435. Epub 2021 May 25.
8
Evaluation and comparison of in vitro intrinsic clearance rates measured using cryopreserved hepatocytes from humans, rats, and rainbow trout.采用人、大鼠和虹鳟鱼冻存肝细胞评估和比较体外内在清除率。
Toxicology. 2021 Jun 15;457:152819. doi: 10.1016/j.tox.2021.152819. Epub 2021 May 10.
9
Development of a Web-Based Toolbox to Support Quantitative In-Vitro-to-In-Vivo Extrapolations (QIVIVE) within Nonanimal Testing Strategies.开发一个基于网络的工具箱,以支持非动物测试策略中的定量体外到体内外推(QIVIVE)。
Chem Res Toxicol. 2021 Feb 15;34(2):460-472. doi: 10.1021/acs.chemrestox.0c00307. Epub 2020 Dec 31.